Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Jun 2;11(1):111.
doi: 10.1186/s13643-022-01922-7.

The effectiveness of smoking cessation interventions for socio-economically disadvantaged women: a systematic review and meta-analysis

Affiliations
Meta-Analysis

The effectiveness of smoking cessation interventions for socio-economically disadvantaged women: a systematic review and meta-analysis

Nicola O'Connell et al. Syst Rev. .

Abstract

Introduction: This systematic review and meta-analysis assessed the effectiveness of smoking cessation interventions among women smokers in low socio-economic status (SES) groups or women living in disadvantaged areas who are historically underserved by smoking cessation services.

Methods: A systematic literature search was conducted using MEDLINE (OVID), EMBASE, Cochrane, CINAHL, PsychINFO and Web of Science databases. Eligibility criteria included randomised controlled trials of any smoking cessation intervention among women in low SES groups or living in socio-economically disadvantaged areas. A random effects meta-analysis assessed effectiveness of interventions on smoking cessation. Risk of bias was assessed with the Cochrane Risk of Bias tool. The GRADE approach established certainty of evidence.

Results: A total of 396 studies were screened for eligibility and 11 (6153 female participants) were included. Seven studies targeted women-only. 5/11 tested a form of face-to-face support. A pooled effect size was estimated in 10/11 studies. At end of treatment, two-thirds more low SES women who received a smoking cessation intervention were more likely to stop smoking than women in control groups (risk ratio (RR) 1.68, 95% CI 1.36-2.08, I2= 34%). The effect was reduced but remained significant when longest available follow-up periods were pooled (RR 1.23, 95% CI 1.04-1.48, I2 = 0%). There was moderate-to-high risk of bias in most studies. Certainty of evidence was low.

Conclusions: Behavioural and behavioural + pharmacotherapy interventions for smoking cessation targeting women in low SES groups or women living in areas of disadvantage were effective in the short term. However, longer follow-up periods indicated reduced effectiveness. Future studies to explore ways to prevent smoking relapse in this population are needed.

Systematic review registration: PROSPERO: CRD42019130160.

Keywords: Behavioural; Cessation; Gender; Health disparities; Meta-analysis; Tobacco control.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
PRISMA flow diagram
Fig. 2
Fig. 2
Smoking cessation in intervention participants versus control participants at end of intervention or at earliest available end point
Fig. 3
Fig. 3
Smoking cessation outcomes in studies with time points available beyond end-of-intervention
Fig. 4
Fig. 4
Funnel plot showing risk of publication bias. The y-axis represents study precision (standard error) and the x-axis represents individual risk ratios. This asymmetric funnel plot suggests the presence of publication bias
Fig. 5
Fig. 5
Interventions targeting only women versus interventions targeting both men and women
Fig. 6
Fig. 6
Comparison of interventions which included biological verification of smoking cessation versus interventions that did not
Fig. 7
Fig. 7
Comparison of studies taking place in clinical settings versus studies in communities
Fig. 8
Fig. 8
Comparison of face-to-face interventions versus other intervention types
Fig. 9
Fig. 9
Comparison of studies testing intervention which included pharmacological therapies versus those that did not include pharmacological therapies

References

    1. World Health Organisation . Tobacco fact sheets. Geneva: WHO; 2019.
    1. Peacock A, Leung J, Larney S, Colledge S, Hickman M, Rehm J, et al. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018;113(10):1905–1926. doi: 10.1111/add.14234. - DOI - PubMed
    1. WHO report on cancer: setting priorities, investing wisely and providing care for all. Geneva: WHO; 2020. Available from: https://www.who.int/publications/i/item/who-report-on-cancer-setting-pri....
    1. US Department of Health and Human Services . The health consequences of smoking - 50 years of progress: a report of the Surgeon General. Atlanta: Centres for Disease Control and Prevention; 2014. - PubMed
    1. Galobardes B, Shaw M, Lawlor DA, Lynch JW, Davey Smith G. Indicators of socioeconomic position (part 1) J Epidemiol Commun H. 2006;60(1):7–12. doi: 10.1136/jech.2004.023531. - DOI - PMC - PubMed

Publication types